STOCK TITAN

Enova International counsel sells 10,000 shares

The 10,000-share sale was executed in multiple trades priced from $183.15 to $183.73 per share.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Enova International, Inc. General Counsel and Secretary Sean Rahilly exercised options for 10,000 common shares on October 29, 2026, at an exercise price of $20.73 per share, then sold 10,000 shares at a weighted average price of $183.2608 per share. The derivative position was reported as 5,000 shares following the transaction, and no Rule 10b5-1 plan is reported.

Insider Rahilly Sean
Role General Counsel and Secretary
Sold 10,000 shs ($1.83M)
Approx. gross sale proceeds $1.83M
Approx. exercise cost $207K
Share of Position Sold 8.8%
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) with limited SAR F2, F3, F4 10,000 $0.00 $0.00
Exercise Common stock, par value $0.00001 per share 10,000 $20.73 $207K
Sale Common stock, par value $0.00001 per share F1 10,000 $183.2608 $1.83M
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 5,000 contracts (Direct); Common stock, par value $0.00001 per share — 104,249 shares (Direct)
Holdings Before and After: Non-Qualified Stock Option (right to buy) with limited SAR, 15,000 to 5,000 contracts (Direct); Common stock, par value $0.00001 per share, 104,249 to 104,249 shares (Direct)
Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
  1. F1. This transaction was executed in multiple trades at prices ranging from $183.15 to $183.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
  2. F2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
  3. F3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
  4. F4. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Options exercised 10,000 shares October 29, 2026
Exercise price $20.73 per share Options exercised October 29, 2026
Shares sold 10,000 shares October 29, 2026
Weighted average sale price $183.2608 per share Multiple trades on October 29, 2026
Sale trade price range $183.15 to $183.73 per share Multiple trades on October 29, 2026
Derivative position following transaction 5,000 shares Reported after the October 29, 2026 transaction
Option expiration date February 11, 2027 Reported derivative position
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
limited stock appreciation right (SAR) financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem"
Offer Value Per Share financial
""Offer Value Per Share" means the average selling price"
weighted average sale price financial
"The price reported above reflects the weighted average sale price"
Change in Control financial
"following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ENVA shares did Sean Rahilly sell, and at what price?

Sean Rahilly sold 10,000 shares on October 29, 2026, at a weighted average price of $183.2608 per share. The sale was executed in multiple trades, and no Rule 10b5-1 plan is reported.

What ENVA options did Sean Rahilly exercise?

Rahilly exercised options for 10,000 shares on October 29, 2026, at an exercise price of $20.73 per share. The derivative position was reported as 5,000 shares following the transaction.

What price range did Sean Rahilly's ENVA stock sale cover?

The multiple trades were priced from $183.15 to $183.73 per share. The reported sale price was the weighted average of those trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rahilly Sean

(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600

(Street)
CHICAGO ILLINOIS 60604

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel and Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00001 per share10/29/2026M10,000A$20.73114,249D
Common stock, par value $0.00001 per share10/29/2026S10,000D$183.2608(1)104,249D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(2)(3)$20.7310/29/2026M10,000 (4)02/11/2027Common stock; par value $0.00001 per share10,000$05,000D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $183.15 to $183.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
4. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
/s/ Sean Rahilly11/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading